Reaction Details  Report a problem with these data
Target
Sepiapterin reductase
Ligand
BDBM659966
Substrate
n/a
Meas. Tech.
Measurement of Human SPR Inhibitory Activity Assay
IC50
0.610±n/a nM
Citation
 KAMAURA, M; INABA, Y; SHINTANI, Y; KUWANO, Y; NAKAO, M; NAGAI, H; KUROSE, N; TAKAYA, K; NAKAJIMA, M CONDENSED HETEROCYCLIC COMPOUND US Patent  US20240092784 Publication Date 3/21/2024
Target
Name:
Sepiapterin reductase
Synonyms:
SPR | SPRE_HUMAN | Sepiapterin reductase (SPR)
Type:
Enzyme
Mol. Mass.:
28050.66
Organism:
Homo sapiens (Human)
Description:
P35270
Residue:
261
Sequence:
MEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK
  
Inhibitor
Name:
BDBM659966
Synonyms:
N-Cyclopropyl-4-hydroxy-1-neopentyl-2,8-dioxo-1,2,7,8,9,10-hexahydropyrido[2',3':3,4]pyrazolo[1,5-a]pyrimidine-3-carboxamide | US20240092784, Example 403
Type:
Small organic molecule
Emp. Form.:
C18H23N5O4
Mol. Mass.:
373.4063
SMILES:
CC(C)(C)Cn1c2c3CCC(=O)Nc3nn2c(O)c(C(=O)NC2CC2)c1=O
Structure:
Search PDB for entries with ligand similarity: